1. Home
  2. PATK vs BLTE Comparison

PATK vs BLTE Comparison

Compare PATK & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patrick Industries Inc.

PATK

Patrick Industries Inc.

HOLD

Current Price

$121.17

Market Cap

3.4B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$178.29

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PATK
BLTE
Founded
1959
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.1B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
PATK
BLTE
Price
$121.17
$178.29
Analyst Decision
Buy
Strong Buy
Analyst Count
8
8
Target Price
$114.63
$181.14
AVG Volume (30 Days)
335.3K
187.8K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
1.53%
N/A
EPS Growth
N/A
N/A
EPS
3.90
N/A
Revenue
$29,000,000.00
N/A
Revenue This Year
$6.11
N/A
Revenue Next Year
$6.73
$218.41
P/E Ratio
$31.38
N/A
Revenue Growth
262.50
N/A
52 Week Low
$72.99
$49.00
52 Week High
$148.50
$200.00

Technical Indicators

Market Signals
Indicator
PATK
BLTE
Relative Strength Index (RSI) 34.98 51.79
Support Level $95.94 $168.00
Resistance Level $135.17 $200.00
Average True Range (ATR) 4.81 8.30
MACD -2.48 -1.62
Stochastic Oscillator 8.69 44.39

Price Performance

Historical Comparison
PATK
BLTE

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: